Vemlidy Coupons & Prices

Vemlidy (tenofovir alafenamide) is a brand-name antiviral FDA-approved to treat chronic hepatitis B virus (HBV) infection in adults and children 6 and older who weigh at least 25 kg and have compensated liver disease. There is currently no generic version, so shoppers searching for a Vemlidy coupon are really comparing the manufacturer's savings card against pharmacy discount programs. Enter your ZIP code above to see today's Vemlidy price at pharmacies near you — the Rx.com cash coupon can help whether or not you have insurance.

What Is Vemlidy and How Does It Work?

Vemlidy's active ingredient, tenofovir alafenamide, belongs to the nucleotide analog reverse transcriptase inhibitor class of antivirals — it's a prodrug form of tenofovir that concentrates in liver cells, where it works to suppress hepatitis B virus replication. Vemlidy is approved specifically for chronic HBV infection in adults and pediatric patients 6 years and older weighing at least 25 kg who have compensated liver disease.

Vemlidy is not approved to treat HIV, and it is not recommended for patients with decompensated (Child-Pugh B or C) liver disease. Only your doctor can confirm whether Vemlidy is appropriate for your situation.

Vemlidy Savings Card vs. the Rx.com Coupon

Gilead, the manufacturer, offers an official Vemlidy Savings Card program through its own website. Like most manufacturer copay cards, it's generally limited to patients with commercial (private) insurance, and eligibility rules and terms can change, so check the current details directly on Gilead's site before assuming you qualify.

If you're uninsured, on Medicare, or your manufacturer card is declined at the pharmacy counter, the Rx.com cash coupon is a separate option that works regardless of insurance status. Because Vemlidy has no generic equivalent yet, pricing can vary by pharmacy — enter your ZIP code above to compare and find a price near you.

Vemlidy vs. Viread, Descovy, and Other HBV Options

Vemlidy isn't the only tenofovir-based option for chronic hepatitis B. Viread (tenofovir disoproxil fumarate) is an older tenofovir prodrug also FDA-approved for chronic HBV; it's dosed differently and has a different kidney/bone safety profile than Vemlidy's tenofovir alafenamide, and a generic version of tenofovir disoproxil fumarate is also available. Entecavir (sold under the brand Baraclude) is a different class of oral antiviral — a nucleoside analog — and is another FDA-approved option for chronic hepatitis B your doctor may discuss with you.

Descovy shares one ingredient (tenofovir alafenamide) with Vemlidy, but it's combined with emtricitabine and is approved for HIV-1 treatment and prevention, not hepatitis B — it is not an interchangeable alternative to Vemlidy. Only your doctor can determine which HBV antiviral is right for you.

Safety Information and Side Effects

Vemlidy carries boxed warnings for lactic acidosis and severe hepatomegaly with steatosis, which have been fatal in some cases, and for severe acute exacerbation of hepatitis B after stopping the drug — your doctor will need to monitor your liver function closely for at least several months after you stop taking Vemlidy. Vemlidy should not be used in patients who also have HIV-1 unless it's part of a complete HIV treatment regimen, since using it alone in that setting can lead to HIV drug resistance.

The most common side effects (reported in 5% or more of patients) include headache, upper respiratory infection, abdominal pain, cough, back pain, joint pain, fatigue, nausea, diarrhea, indigestion, and fever. This isn't a complete list — talk with your doctor or pharmacist about your full medical history before starting Vemlidy, and don't stop taking it without medical guidance.